Biofrontera Inc. SEC filings BFRIW
Biofrontera Inc. has 365 filings in SEC EDGAR's recent list, going back to May 7, 2021. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Other events
|
Feb 26, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 7, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Other events
|
Nov 10, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Nov 7, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
|
Oct 24, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 19, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K/A | Amended current report | Jul 16, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Jul 1, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Listing notice
|
May 23, 2025 | May 21, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Listing notice
|
May 14, 2025 | May 8, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 18, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Material agreement, New debt, Listing notice
|
Nov 27, 2024 | Nov 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 22, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Other events
|
May 22, 2024 | May 17, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 3, 2024 | May 2, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 30, 2024 | Apr 25, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Apr 25, 2024 | Apr 24, 2024 |
| 8-K/A |
Amended current report
Other events
|
Apr 3, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Other events
|
Mar 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Feb 23, 2024 | Feb 19, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Feb 20, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Other events
|
Feb 13, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 5, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 2, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 25, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 11, 2024 | Jan 11, 2024 |
| 8-K/A |
Amended current report
Agreement ended
|
Jan 9, 2024 | Dec 21, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 3, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Dec 28, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Dec 27, 2023 | Dec 20, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 15, 2023 | Dec 12, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 29, 2023 | Nov 22, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Regulation FD disclosure
|
Nov 2, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 13, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 4, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Other events
|
Oct 3, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 13, 2023 | Jul 13, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 12, 2023 | Jul 7, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 3, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Auditor change
|
Jun 20, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Auditor change
|
Jun 2, 2023 | May 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 1, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Listing notice, Officer or director change, Shareholder vote results
|
May 26, 2023 | May 22, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
May 12, 2023 | May 8, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Apr 28, 2023 | Apr 26, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 17, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Listing notice
|
Mar 2, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 16, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 9, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 31, 2022 | Oct 25, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 24, 2022 | Oct 24, 2022 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Oct 14, 2022 | Oct 13, 2022 |
| 8-K |
Current report
Results of operations
|
Oct 5, 2022 | Oct 5, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Jul 28, 2022 | Jul 27, 2022 |
| 8-K |
Current report
Results of operations
|
Jul 12, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
May 24, 2022 | May 18, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
May 24, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 20, 2022 | May 20, 2022 |
| 8-K |
Current report
Results of operations
|
May 13, 2022 | May 13, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 8, 2022 | Apr 8, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 6, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Apr 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2022 | Jan 13, 2022 |
| 8-K |
Current report
Other events
|
Dec 29, 2021 | Dec 28, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 3, 2021 | Dec 3, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 30, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 29, 2021 | Nov 29, 2021 |
| 8-K |
Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Other events
|
Nov 3, 2021 | Nov 3, 2021 |
Showing 103 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BFRI (Nasdaq), BFRIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Woburn, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1858685
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.